InforSense® Announces Conference Series
News Nov 14, 2006
InforSense Ltd. has announced three upcoming InforSense-hosted conferences. The Statistical Genetics Workshop, co-chaired by Dr Jean-Pierre Kocher, Bioinformatics Core Director at the Mayo Clinic and Jonathan Sheldon, CSO at InforSense, will bring together thought leaders and practitioners in the Statistical Genetics arena to share case studies and best practices in this evolving field - from data cleaning to advanced statistical methods.
The Agenda features presentations from key players in the field and an open panel discussion. The agenda, list of registered speakers and registration form are available online.
The InforSense Users Conference will provide you with the opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.
Contributions from Keynote Speakers, InforSense KDE users, Partners and InforSense Product Specialists will help you to maximize the value of InforSense technology in your organization.
Register online to reserve your place and receive further information on the Users Conference.
The Translational Medicine Symposium will bring together thought leaders and practitioners in the Translational Medicine arena - from pharmaceutical and biotechnology organizations, biomedical research institutes and academia - to explore current trends, opportunities and unmet needs.
The Symposium will provide an opportunity for key players in the field to present the current practices through invited scientific and technical presentations.
It will also provide a forum to discuss the requirements for informatics between and across the many different disciplines that comprise Translational Medicine.
For the agenda, list of speakers and registration form visit Company website.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018